nodes	percent_of_prediction	percent_of_DWPC	metapath
Remifentanil—Sufentanil—CYP3A4—type 2 diabetes mellitus	0.00221	0.259	CrCbGaD
Remifentanil—Alfentanil—CYP3A4—type 2 diabetes mellitus	0.00205	0.24	CrCbGaD
Remifentanil—Alfentanil—ALB—type 2 diabetes mellitus	0.00179	0.21	CrCbGaD
Remifentanil—Pethidine—CYP3A4—type 2 diabetes mellitus	0.000924	0.108	CrCbGaD
Remifentanil—Pethidine—ALB—type 2 diabetes mellitus	0.000806	0.0946	CrCbGaD
Remifentanil—Fentanyl—CYP3A4—type 2 diabetes mellitus	0.000751	0.088	CrCbGaD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	0.000674	0.000852	CcSEcCtD
Remifentanil—Dry mouth—Valsartan—type 2 diabetes mellitus	0.000672	0.000849	CcSEcCtD
Remifentanil—Hypotension—Gliclazide—type 2 diabetes mellitus	0.00067	0.000846	CcSEcCtD
Remifentanil—Arrhythmia—Losartan—type 2 diabetes mellitus	0.000669	0.000846	CcSEcCtD
Remifentanil—Dry mouth—Orlistat—type 2 diabetes mellitus	0.000664	0.000839	CcSEcCtD
Remifentanil—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000662	0.000837	CcSEcCtD
Remifentanil—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.00066	0.000834	CcSEcCtD
Remifentanil—Vomiting—Glipizide—type 2 diabetes mellitus	0.000659	0.000833	CcSEcCtD
Remifentanil—Syncope—Metformin—type 2 diabetes mellitus	0.000659	0.000833	CcSEcCtD
Remifentanil—Oedema—Valsartan—type 2 diabetes mellitus	0.000658	0.000832	CcSEcCtD
Remifentanil—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.000658	0.000832	CcSEcCtD
Remifentanil—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.000658	0.000831	CcSEcCtD
Remifentanil—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000657	0.00083	CcSEcCtD
Remifentanil—Rash—Glipizide—type 2 diabetes mellitus	0.000654	0.000826	CcSEcCtD
Remifentanil—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000653	0.000826	CcSEcCtD
Remifentanil—Erythema—Losartan—type 2 diabetes mellitus	0.000652	0.000825	CcSEcCtD
Remifentanil—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.000651	0.000822	CcSEcCtD
Remifentanil—Oedema—Orlistat—type 2 diabetes mellitus	0.000651	0.000822	CcSEcCtD
Remifentanil—Headache—Glipizide—type 2 diabetes mellitus	0.00065	0.000821	CcSEcCtD
Remifentanil—Tremor—Irbesartan—type 2 diabetes mellitus	0.000649	0.000821	CcSEcCtD
Remifentanil—Shock—Valsartan—type 2 diabetes mellitus	0.000648	0.000819	CcSEcCtD
Remifentanil—Loss of consciousness—Metformin—type 2 diabetes mellitus	0.000646	0.000816	CcSEcCtD
Remifentanil—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.000646	0.000816	CcSEcCtD
Remifentanil—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.000645	0.000815	CcSEcCtD
Remifentanil—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.000643	0.000813	CcSEcCtD
Remifentanil—Anaemia—Irbesartan—type 2 diabetes mellitus	0.000641	0.00081	CcSEcCtD
Remifentanil—Dizziness—Glimepiride—type 2 diabetes mellitus	0.00064	0.000809	CcSEcCtD
Remifentanil—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000639	0.000808	CcSEcCtD
Remifentanil—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.000639	0.000808	CcSEcCtD
Remifentanil—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000638	0.000806	CcSEcCtD
Remifentanil—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000638	0.000806	CcSEcCtD
Remifentanil—Agitation—Irbesartan—type 2 diabetes mellitus	0.000637	0.000805	CcSEcCtD
Remifentanil—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000637	0.000805	CcSEcCtD
Remifentanil—Hypertension—Metformin—type 2 diabetes mellitus	0.000634	0.000802	CcSEcCtD
Remifentanil—Urticaria—Glyburide—type 2 diabetes mellitus	0.000634	0.000801	CcSEcCtD
Remifentanil—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000632	0.000799	CcSEcCtD
Remifentanil—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000631	0.000797	CcSEcCtD
Remifentanil—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.000629	0.000795	CcSEcCtD
Remifentanil—Headache—Pioglitazone—type 2 diabetes mellitus	0.000622	0.000787	CcSEcCtD
Remifentanil—Syncope—Irbesartan—type 2 diabetes mellitus	0.000622	0.000786	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000621	0.000785	CcSEcCtD
Remifentanil—Visual impairment—Ramipril—type 2 diabetes mellitus	0.000619	0.000783	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000619	0.000782	CcSEcCtD
Remifentanil—Nausea—Glipizide—type 2 diabetes mellitus	0.000616	0.000779	CcSEcCtD
Remifentanil—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000615	0.000778	CcSEcCtD
Remifentanil—Hypotension—Valsartan—type 2 diabetes mellitus	0.000615	0.000778	CcSEcCtD
Remifentanil—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000613	0.000775	CcSEcCtD
Remifentanil—Pain—Gliclazide—type 2 diabetes mellitus	0.000613	0.000775	CcSEcCtD
Remifentanil—Constipation—Gliclazide—type 2 diabetes mellitus	0.000613	0.000775	CcSEcCtD
Remifentanil—Tremor—Losartan—type 2 diabetes mellitus	0.000611	0.000773	CcSEcCtD
Remifentanil—Rash—Glimepiride—type 2 diabetes mellitus	0.00061	0.000771	CcSEcCtD
Remifentanil—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.00061	0.000771	CcSEcCtD
Remifentanil—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	0.000609	0.00077	CcSEcCtD
Remifentanil—Rash—Sitagliptin—type 2 diabetes mellitus	0.000608	0.000769	CcSEcCtD
Remifentanil—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000608	0.000768	CcSEcCtD
Remifentanil—Headache—Glimepiride—type 2 diabetes mellitus	0.000606	0.000766	CcSEcCtD
Remifentanil—Cough—Irbesartan—type 2 diabetes mellitus	0.000605	0.000765	CcSEcCtD
Remifentanil—Headache—Sitagliptin—type 2 diabetes mellitus	0.000604	0.000764	CcSEcCtD
Remifentanil—Anaemia—Losartan—type 2 diabetes mellitus	0.000603	0.000762	CcSEcCtD
Remifentanil—Agitation—Losartan—type 2 diabetes mellitus	0.0006	0.000758	CcSEcCtD
Remifentanil—Oedema—Metformin—type 2 diabetes mellitus	0.000599	0.000758	CcSEcCtD
Remifentanil—Hypertension—Irbesartan—type 2 diabetes mellitus	0.000598	0.000757	CcSEcCtD
Remifentanil—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000597	0.000755	CcSEcCtD
Remifentanil—Flushing—Ramipril—type 2 diabetes mellitus	0.000596	0.000754	CcSEcCtD
Remifentanil—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000591	0.000747	CcSEcCtD
Remifentanil—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.00059	0.000746	CcSEcCtD
Remifentanil—Shock—Metformin—type 2 diabetes mellitus	0.00059	0.000746	CcSEcCtD
Remifentanil—Anxiety—Irbesartan—type 2 diabetes mellitus	0.000588	0.000743	CcSEcCtD
Remifentanil—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000588	0.000743	CcSEcCtD
Remifentanil—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000588	0.000743	CcSEcCtD
Remifentanil—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000587	0.000742	CcSEcCtD
Remifentanil—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000587	0.000742	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000586	0.000741	CcSEcCtD
Remifentanil—Somnolence—Valsartan—type 2 diabetes mellitus	0.000585	0.00074	CcSEcCtD
Remifentanil—Syncope—Losartan—type 2 diabetes mellitus	0.000585	0.00074	CcSEcCtD
Remifentanil—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000584	0.000738	CcSEcCtD
Remifentanil—Skin disorder—Metformin—type 2 diabetes mellitus	0.000582	0.000736	CcSEcCtD
Remifentanil—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.00058	0.000734	CcSEcCtD
Remifentanil—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.00058	0.000733	CcSEcCtD
Remifentanil—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000579	0.000733	CcSEcCtD
Remifentanil—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	0.000579	0.000732	CcSEcCtD
Remifentanil—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000577	0.00073	CcSEcCtD
Remifentanil—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000577	0.00073	CcSEcCtD
Remifentanil—Nausea—Glimepiride—type 2 diabetes mellitus	0.000575	0.000727	CcSEcCtD
Remifentanil—Arrhythmia—Ramipril—type 2 diabetes mellitus	0.000574	0.000726	CcSEcCtD
Remifentanil—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.000573	0.000725	CcSEcCtD
Remifentanil—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000573	0.000724	CcSEcCtD
Remifentanil—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000573	0.000724	CcSEcCtD
Remifentanil—Cough—Losartan—type 2 diabetes mellitus	0.000569	0.00072	CcSEcCtD
Remifentanil—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000569	0.00072	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000568	0.000718	CcSEcCtD
Remifentanil—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000566	0.000716	CcSEcCtD
Remifentanil—Oedema—Irbesartan—type 2 diabetes mellitus	0.000566	0.000715	CcSEcCtD
Remifentanil—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000566	0.000715	CcSEcCtD
Remifentanil—Pruritus—Glyburide—type 2 diabetes mellitus	0.000565	0.000714	CcSEcCtD
Remifentanil—Constipation—Valsartan—type 2 diabetes mellitus	0.000563	0.000712	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000562	0.00071	CcSEcCtD
Remifentanil—Hypotension—Metformin—type 2 diabetes mellitus	0.00056	0.000708	CcSEcCtD
Remifentanil—Erythema—Ramipril—type 2 diabetes mellitus	0.000559	0.000707	CcSEcCtD
Remifentanil—Shock—Irbesartan—type 2 diabetes mellitus	0.000557	0.000704	CcSEcCtD
Remifentanil—Pain—Orlistat—type 2 diabetes mellitus	0.000556	0.000703	CcSEcCtD
Remifentanil—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000555	0.000702	CcSEcCtD
Remifentanil—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000555	0.000701	CcSEcCtD
Remifentanil—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000554	0.0007	CcSEcCtD
Remifentanil—Anxiety—Losartan—type 2 diabetes mellitus	0.000553	0.0007	CcSEcCtD
Remifentanil—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000552	0.000698	CcSEcCtD
Remifentanil—Rash—Bromocriptine—type 2 diabetes mellitus	0.00055	0.000696	CcSEcCtD
Remifentanil—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.00055	0.000695	CcSEcCtD
Remifentanil—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.00055	0.000695	CcSEcCtD
Remifentanil—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000547	0.000691	CcSEcCtD
Remifentanil—Headache—Bromocriptine—type 2 diabetes mellitus	0.000547	0.000691	CcSEcCtD
Remifentanil—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000546	0.00069	CcSEcCtD
Remifentanil—Dry mouth—Losartan—type 2 diabetes mellitus	0.000543	0.000687	CcSEcCtD
Remifentanil—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000538	0.00068	CcSEcCtD
Remifentanil—Confusional state—Losartan—type 2 diabetes mellitus	0.000537	0.000679	CcSEcCtD
Remifentanil—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000536	0.000678	CcSEcCtD
Remifentanil—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000534	0.000676	CcSEcCtD
Remifentanil—Somnolence—Metformin—type 2 diabetes mellitus	0.000533	0.000674	CcSEcCtD
Remifentanil—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000532	0.000673	CcSEcCtD
Remifentanil—Oedema—Losartan—type 2 diabetes mellitus	0.000532	0.000673	CcSEcCtD
Remifentanil—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000529	0.000668	CcSEcCtD
Remifentanil—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000528	0.000667	CcSEcCtD
Remifentanil—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000528	0.000667	CcSEcCtD
Remifentanil—Tremor—Ramipril—type 2 diabetes mellitus	0.000524	0.000663	CcSEcCtD
Remifentanil—Shock—Losartan—type 2 diabetes mellitus	0.000524	0.000662	CcSEcCtD
Remifentanil—Urticaria—Valsartan—type 2 diabetes mellitus	0.000523	0.000661	CcSEcCtD
Remifentanil—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000522	0.00066	CcSEcCtD
Remifentanil—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.000521	0.000659	CcSEcCtD
Remifentanil—Tachycardia—Losartan—type 2 diabetes mellitus	0.00052	0.000657	CcSEcCtD
Remifentanil—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000518	0.000655	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000518	0.000654	CcSEcCtD
Remifentanil—Urticaria—Orlistat—type 2 diabetes mellitus	0.000517	0.000653	CcSEcCtD
Remifentanil—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.000515	0.000651	CcSEcCtD
Remifentanil—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000514	0.00065	CcSEcCtD
Remifentanil—Agitation—Ramipril—type 2 diabetes mellitus	0.000514	0.00065	CcSEcCtD
Remifentanil—Constipation—Metformin—type 2 diabetes mellitus	0.000513	0.000648	CcSEcCtD
Remifentanil—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000508	0.000642	CcSEcCtD
Remifentanil—Vomiting—Glyburide—type 2 diabetes mellitus	0.000507	0.000641	CcSEcCtD
Remifentanil—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000507	0.000641	CcSEcCtD
Remifentanil—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000504	0.000638	CcSEcCtD
Remifentanil—Rash—Glyburide—type 2 diabetes mellitus	0.000503	0.000636	CcSEcCtD
Remifentanil—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000503	0.000636	CcSEcCtD
Remifentanil—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000503	0.000635	CcSEcCtD
Remifentanil—Syncope—Ramipril—type 2 diabetes mellitus	0.000502	0.000634	CcSEcCtD
Remifentanil—Headache—Glyburide—type 2 diabetes mellitus	0.0005	0.000632	CcSEcCtD
Remifentanil—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000498	0.00063	CcSEcCtD
Remifentanil—Hypotension—Losartan—type 2 diabetes mellitus	0.000498	0.000629	CcSEcCtD
Remifentanil—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000494	0.000624	CcSEcCtD
Remifentanil—Loss of consciousness—Ramipril—type 2 diabetes mellitus	0.000492	0.000622	CcSEcCtD
Remifentanil—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.00049	0.00062	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000488	0.000617	CcSEcCtD
Remifentanil—Cough—Ramipril—type 2 diabetes mellitus	0.000488	0.000617	CcSEcCtD
Remifentanil—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000485	0.000613	CcSEcCtD
Remifentanil—Convulsion—Ramipril—type 2 diabetes mellitus	0.000485	0.000613	CcSEcCtD
Remifentanil—Pain—Irbesartan—type 2 diabetes mellitus	0.000484	0.000612	CcSEcCtD
Remifentanil—Constipation—Irbesartan—type 2 diabetes mellitus	0.000484	0.000612	CcSEcCtD
Remifentanil—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000479	0.000606	CcSEcCtD
Remifentanil—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000478	0.000604	CcSEcCtD
Remifentanil—Urticaria—Metformin—type 2 diabetes mellitus	0.000476	0.000602	CcSEcCtD
Remifentanil—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000475	0.0006	CcSEcCtD
Remifentanil—Anxiety—Ramipril—type 2 diabetes mellitus	0.000475	0.0006	CcSEcCtD
Remifentanil—Nausea—Glyburide—type 2 diabetes mellitus	0.000474	0.000599	CcSEcCtD
Remifentanil—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000474	0.000599	CcSEcCtD
Remifentanil—Somnolence—Losartan—type 2 diabetes mellitus	0.000473	0.000598	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000473	0.000598	CcSEcCtD
Remifentanil—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000469	0.000592	CcSEcCtD
Remifentanil—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000466	0.000589	CcSEcCtD
Remifentanil—Pruritus—Valsartan—type 2 diabetes mellitus	0.000466	0.000589	CcSEcCtD
Remifentanil—Dry mouth—Ramipril—type 2 diabetes mellitus	0.000466	0.000589	CcSEcCtD
Remifentanil—Confusional state—Ramipril—type 2 diabetes mellitus	0.00046	0.000582	CcSEcCtD
Remifentanil—Pruritus—Orlistat—type 2 diabetes mellitus	0.00046	0.000582	CcSEcCtD
Remifentanil—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.000457	0.000577	CcSEcCtD
Remifentanil—Oedema—Ramipril—type 2 diabetes mellitus	0.000457	0.000577	CcSEcCtD
Remifentanil—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000456	0.000576	CcSEcCtD
Remifentanil—Pain—Losartan—type 2 diabetes mellitus	0.000455	0.000576	CcSEcCtD
Remifentanil—Constipation—Losartan—type 2 diabetes mellitus	0.000455	0.000576	CcSEcCtD
Remifentanil—Rash—Gliclazide—type 2 diabetes mellitus	0.000452	0.000571	CcSEcCtD
Remifentanil—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000451	0.000571	CcSEcCtD
Remifentanil—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.00045	0.000569	CcSEcCtD
Remifentanil—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000449	0.000568	CcSEcCtD
Remifentanil—Shock—Ramipril—type 2 diabetes mellitus	0.000449	0.000568	CcSEcCtD
Remifentanil—Headache—Gliclazide—type 2 diabetes mellitus	0.000449	0.000567	CcSEcCtD
Remifentanil—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000448	0.000566	CcSEcCtD
Remifentanil—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000447	0.000565	CcSEcCtD
Remifentanil—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	0.000447	0.000565	CcSEcCtD
Remifentanil—Tachycardia—Ramipril—type 2 diabetes mellitus	0.000446	0.000563	CcSEcCtD
Remifentanil—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000445	0.000563	CcSEcCtD
Remifentanil—Skin disorder—Ramipril—type 2 diabetes mellitus	0.000443	0.000561	CcSEcCtD
Remifentanil—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	0.000441	0.000558	CcSEcCtD
Remifentanil—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.000439	0.000555	CcSEcCtD
Remifentanil—Dizziness—Valsartan—type 2 diabetes mellitus	0.000435	0.00055	CcSEcCtD
Remifentanil—Dizziness—Orlistat—type 2 diabetes mellitus	0.00043	0.000544	CcSEcCtD
Remifentanil—Hypotension—Ramipril—type 2 diabetes mellitus	0.000427	0.000539	CcSEcCtD
Remifentanil—Nausea—Gliclazide—type 2 diabetes mellitus	0.000426	0.000538	CcSEcCtD
Remifentanil—Pruritus—Metformin—type 2 diabetes mellitus	0.000424	0.000536	CcSEcCtD
Remifentanil—Urticaria—Losartan—type 2 diabetes mellitus	0.000423	0.000535	CcSEcCtD
Remifentanil—Body temperature increased—Losartan—type 2 diabetes mellitus	0.000421	0.000532	CcSEcCtD
Remifentanil—Vomiting—Valsartan—type 2 diabetes mellitus	0.000419	0.000529	CcSEcCtD
Remifentanil—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000417	0.000527	CcSEcCtD
Remifentanil—Rash—Valsartan—type 2 diabetes mellitus	0.000415	0.000525	CcSEcCtD
Remifentanil—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000415	0.000524	CcSEcCtD
Remifentanil—Vomiting—Orlistat—type 2 diabetes mellitus	0.000414	0.000523	CcSEcCtD
Remifentanil—Headache—Valsartan—type 2 diabetes mellitus	0.000412	0.000521	CcSEcCtD
Remifentanil—Diarrhoea—Metformin—type 2 diabetes mellitus	0.00041	0.000519	CcSEcCtD
Remifentanil—Rash—Orlistat—type 2 diabetes mellitus	0.00041	0.000518	CcSEcCtD
Remifentanil—Paraesthesia—Ramipril—type 2 diabetes mellitus	0.00041	0.000518	CcSEcCtD
Remifentanil—Dermatitis—Orlistat—type 2 diabetes mellitus	0.00041	0.000518	CcSEcCtD
Remifentanil—Headache—Orlistat—type 2 diabetes mellitus	0.000408	0.000515	CcSEcCtD
Remifentanil—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.000407	0.000515	CcSEcCtD
Remifentanil—Somnolence—Ramipril—type 2 diabetes mellitus	0.000406	0.000513	CcSEcCtD
Remifentanil—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.000402	0.000508	CcSEcCtD
Remifentanil—Pruritus—Irbesartan—type 2 diabetes mellitus	0.0004	0.000506	CcSEcCtD
Remifentanil—Dizziness—Metformin—type 2 diabetes mellitus	0.000396	0.000501	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000394	0.000498	CcSEcCtD
Remifentanil—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000392	0.000496	CcSEcCtD
Remifentanil—Nausea—Valsartan—type 2 diabetes mellitus	0.000391	0.000494	CcSEcCtD
Remifentanil—Constipation—Ramipril—type 2 diabetes mellitus	0.00039	0.000494	CcSEcCtD
Remifentanil—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000387	0.000489	CcSEcCtD
Remifentanil—Nausea—Orlistat—type 2 diabetes mellitus	0.000386	0.000488	CcSEcCtD
Remifentanil—Vomiting—Metformin—type 2 diabetes mellitus	0.000381	0.000482	CcSEcCtD
Remifentanil—Rash—Metformin—type 2 diabetes mellitus	0.000378	0.000478	CcSEcCtD
Remifentanil—Dermatitis—Metformin—type 2 diabetes mellitus	0.000378	0.000477	CcSEcCtD
Remifentanil—Pruritus—Losartan—type 2 diabetes mellitus	0.000377	0.000476	CcSEcCtD
Remifentanil—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.000376	0.000476	CcSEcCtD
Remifentanil—Headache—Metformin—type 2 diabetes mellitus	0.000376	0.000475	CcSEcCtD
Remifentanil—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000374	0.000473	CcSEcCtD
Remifentanil—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000364	0.000461	CcSEcCtD
Remifentanil—Urticaria—Ramipril—type 2 diabetes mellitus	0.000363	0.000458	CcSEcCtD
Remifentanil—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.000361	0.000456	CcSEcCtD
Remifentanil—Vomiting—Irbesartan—type 2 diabetes mellitus	0.00036	0.000455	CcSEcCtD
Remifentanil—Rash—Irbesartan—type 2 diabetes mellitus	0.000357	0.000451	CcSEcCtD
Remifentanil—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000356	0.000451	CcSEcCtD
Remifentanil—Nausea—Metformin—type 2 diabetes mellitus	0.000356	0.00045	CcSEcCtD
Remifentanil—Headache—Irbesartan—type 2 diabetes mellitus	0.000354	0.000448	CcSEcCtD
Remifentanil—Dizziness—Losartan—type 2 diabetes mellitus	0.000352	0.000445	CcSEcCtD
Remifentanil—Vomiting—Losartan—type 2 diabetes mellitus	0.000339	0.000428	CcSEcCtD
Remifentanil—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000336	0.000425	CcSEcCtD
Remifentanil—Nausea—Irbesartan—type 2 diabetes mellitus	0.000336	0.000425	CcSEcCtD
Remifentanil—Rash—Losartan—type 2 diabetes mellitus	0.000336	0.000424	CcSEcCtD
Remifentanil—Dermatitis—Losartan—type 2 diabetes mellitus	0.000335	0.000424	CcSEcCtD
Remifentanil—Headache—Losartan—type 2 diabetes mellitus	0.000334	0.000422	CcSEcCtD
Remifentanil—Pruritus—Ramipril—type 2 diabetes mellitus	0.000323	0.000408	CcSEcCtD
Remifentanil—Nausea—Losartan—type 2 diabetes mellitus	0.000316	0.0004	CcSEcCtD
Remifentanil—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000312	0.000395	CcSEcCtD
Remifentanil—Dizziness—Ramipril—type 2 diabetes mellitus	0.000302	0.000382	CcSEcCtD
Remifentanil—Vomiting—Ramipril—type 2 diabetes mellitus	0.00029	0.000367	CcSEcCtD
Remifentanil—Rash—Ramipril—type 2 diabetes mellitus	0.000288	0.000364	CcSEcCtD
Remifentanil—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000288	0.000364	CcSEcCtD
Remifentanil—Headache—Ramipril—type 2 diabetes mellitus	0.000286	0.000362	CcSEcCtD
Remifentanil—Nausea—Ramipril—type 2 diabetes mellitus	0.000271	0.000343	CcSEcCtD
Remifentanil—OPRD1—GPCR downstream signaling—AGT—type 2 diabetes mellitus	0.000118	0.000589	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—TRPC6—type 2 diabetes mellitus	0.000118	0.000588	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	0.000118	0.000587	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CCKAR—type 2 diabetes mellitus	0.000117	0.000586	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—ADRB3—type 2 diabetes mellitus	0.000117	0.000585	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—AGTR2—type 2 diabetes mellitus	0.000117	0.000584	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—RASGRP1—type 2 diabetes mellitus	0.000116	0.000581	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—CCR5—type 2 diabetes mellitus	0.000115	0.000576	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—EDN1—type 2 diabetes mellitus	0.000113	0.000565	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CRHR1—type 2 diabetes mellitus	0.000113	0.000565	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—C3—type 2 diabetes mellitus	0.000113	0.000563	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—GNB3—type 2 diabetes mellitus	0.000112	0.000561	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—EDNRB—type 2 diabetes mellitus	0.000112	0.000559	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	0.000112	0.000556	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—AVP—type 2 diabetes mellitus	0.000111	0.000553	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	0.000109	0.000544	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—C3—type 2 diabetes mellitus	0.000109	0.000544	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—HTR2C—type 2 diabetes mellitus	0.000109	0.000543	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—PSMD6—type 2 diabetes mellitus	0.000109	0.000543	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	0.000108	0.000537	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—AGT—type 2 diabetes mellitus	0.000107	0.000535	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	0.000106	0.000531	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—EDNRA—type 2 diabetes mellitus	0.000106	0.000528	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—IAPP—type 2 diabetes mellitus	0.000106	0.000528	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—CALM1—type 2 diabetes mellitus	0.000105	0.000526	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—EDN1—type 2 diabetes mellitus	0.000105	0.000526	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CYBA—type 2 diabetes mellitus	0.000105	0.000526	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—INSR—type 2 diabetes mellitus	0.000105	0.000524	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PRKAA1—type 2 diabetes mellitus	0.000104	0.000521	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	0.000104	0.000517	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—AGT—type 2 diabetes mellitus	0.000104	0.000517	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—MTNR1B—type 2 diabetes mellitus	0.000104	0.000517	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—SPRY2—type 2 diabetes mellitus	0.000104	0.000517	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—TRPC6—type 2 diabetes mellitus	0.000103	0.000515	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—PLAT—type 2 diabetes mellitus	0.000103	0.000515	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—GHRL—type 2 diabetes mellitus	0.000103	0.000515	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	0.000103	0.000515	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—AGTR2—type 2 diabetes mellitus	0.000103	0.000512	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—GNB3—type 2 diabetes mellitus	0.000102	0.000509	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CALCA—type 2 diabetes mellitus	0.000102	0.000509	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—CCR5—type 2 diabetes mellitus	0.000101	0.000505	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—RBP4—type 2 diabetes mellitus	0.000101	0.000503	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—GLP1R—type 2 diabetes mellitus	0.000101	0.000503	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—AVP—type 2 diabetes mellitus	0.000101	0.000502	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—MMP3—type 2 diabetes mellitus	0.000101	0.000502	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—ADCY5—type 2 diabetes mellitus	0.0001	0.0005	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CCKAR—type 2 diabetes mellitus	9.93e-05	0.000495	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	9.91e-05	0.000494	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—C3—type 2 diabetes mellitus	9.9e-05	0.000494	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—EDNRB—type 2 diabetes mellitus	9.83e-05	0.000491	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	9.6e-05	0.000479	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—EDN1—type 2 diabetes mellitus	9.57e-05	0.000478	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	9.57e-05	0.000477	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	9.55e-05	0.000477	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PSMD6—type 2 diabetes mellitus	9.54e-05	0.000476	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—HTR2C—type 2 diabetes mellitus	9.54e-05	0.000476	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—PTPN1—type 2 diabetes mellitus	9.44e-05	0.000471	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—GCG—type 2 diabetes mellitus	9.44e-05	0.000471	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	9.42e-05	0.00047	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—AGT—type 2 diabetes mellitus	9.4e-05	0.000469	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	9.28e-05	0.000463	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—EDNRA—type 2 diabetes mellitus	9.28e-05	0.000463	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	9.25e-05	0.000462	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—CALM1—type 2 diabetes mellitus	9.25e-05	0.000461	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CYBA—type 2 diabetes mellitus	9.24e-05	0.000461	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—C3—type 2 diabetes mellitus	9.21e-05	0.00046	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	9.09e-05	0.000454	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	9.08e-05	0.000453	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PLAT—type 2 diabetes mellitus	9.05e-05	0.000451	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—GHRL—type 2 diabetes mellitus	9.05e-05	0.000451	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	8.99e-05	0.000449	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—IAPP—type 2 diabetes mellitus	8.94e-05	0.000446	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CALCA—type 2 diabetes mellitus	8.94e-05	0.000446	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—INSR—type 2 diabetes mellitus	8.88e-05	0.000443	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—CCL2—type 2 diabetes mellitus	8.83e-05	0.000441	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—AGT—type 2 diabetes mellitus	8.75e-05	0.000437	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—TRPC6—type 2 diabetes mellitus	8.73e-05	0.000435	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	8.72e-05	0.000435	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	8.69e-05	0.000434	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—AKT2—type 2 diabetes mellitus	8.68e-05	0.000433	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—AGTR2—type 2 diabetes mellitus	8.68e-05	0.000433	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	8.67e-05	0.000433	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—CCR5—type 2 diabetes mellitus	8.56e-05	0.000427	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	8.42e-05	0.00042	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	8.38e-05	0.000418	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—C3—type 2 diabetes mellitus	8.36e-05	0.000417	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—EDNRB—type 2 diabetes mellitus	8.31e-05	0.000415	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—GCG—type 2 diabetes mellitus	8.27e-05	0.000413	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PTPN1—type 2 diabetes mellitus	8.27e-05	0.000413	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	8.21e-05	0.00041	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	8.14e-05	0.000406	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—GNB3—type 2 diabetes mellitus	8.13e-05	0.000406	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	8.11e-05	0.000405	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	8.09e-05	0.000403	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—HTR2C—type 2 diabetes mellitus	8.07e-05	0.000402	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PSMD6—type 2 diabetes mellitus	8.07e-05	0.000402	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—AVP—type 2 diabetes mellitus	8.02e-05	0.0004	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—MMP3—type 2 diabetes mellitus	8.02e-05	0.0004	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—IGF2—type 2 diabetes mellitus	7.99e-05	0.000399	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	7.95e-05	0.000397	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—AGT—type 2 diabetes mellitus	7.95e-05	0.000397	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	7.87e-05	0.000393	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—EDNRA—type 2 diabetes mellitus	7.85e-05	0.000392	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—CALM1—type 2 diabetes mellitus	7.81e-05	0.00039	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CYBA—type 2 diabetes mellitus	7.81e-05	0.00039	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—APOB—type 2 diabetes mellitus	7.75e-05	0.000387	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—CCL2—type 2 diabetes mellitus	7.74e-05	0.000386	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	7.72e-05	0.000385	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	7.68e-05	0.000383	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—GHRL—type 2 diabetes mellitus	7.65e-05	0.000382	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PLAT—type 2 diabetes mellitus	7.65e-05	0.000382	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—EDN1—type 2 diabetes mellitus	7.63e-05	0.000381	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—AKT2—type 2 diabetes mellitus	7.61e-05	0.00038	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	7.6e-05	0.000379	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CALCA—type 2 diabetes mellitus	7.55e-05	0.000377	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—LPL—type 2 diabetes mellitus	7.4e-05	0.000369	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	7.34e-05	0.000366	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	7.25e-05	0.000362	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	7.2e-05	0.000359	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—GNB3—type 2 diabetes mellitus	7.13e-05	0.000356	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	7.11e-05	0.000355	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	7.08e-05	0.000353	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—AVP—type 2 diabetes mellitus	7.04e-05	0.000351	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—MMP3—type 2 diabetes mellitus	7.04e-05	0.000351	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—IGF2—type 2 diabetes mellitus	7e-05	0.00035	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—GCG—type 2 diabetes mellitus	6.99e-05	0.000349	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PTPN1—type 2 diabetes mellitus	6.99e-05	0.000349	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	6.97e-05	0.000348	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	6.95e-05	0.000347	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	6.9e-05	0.000344	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	6.88e-05	0.000343	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	6.86e-05	0.000342	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CCR5—type 2 diabetes mellitus	6.82e-05	0.00034	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—APOB—type 2 diabetes mellitus	6.8e-05	0.000339	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	6.77e-05	0.000338	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—EDN1—type 2 diabetes mellitus	6.69e-05	0.000334	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—C3—type 2 diabetes mellitus	6.67e-05	0.000333	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—CCL2—type 2 diabetes mellitus	6.54e-05	0.000327	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—LPL—type 2 diabetes mellitus	6.49e-05	0.000324	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—AKT2—type 2 diabetes mellitus	6.43e-05	0.000321	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	6.42e-05	0.000321	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	6.36e-05	0.000317	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	6.36e-05	0.000317	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—IRS2—type 2 diabetes mellitus	6.34e-05	0.000316	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—AGT—type 2 diabetes mellitus	6.33e-05	0.000316	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CALM1—type 2 diabetes mellitus	6.23e-05	0.000311	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—APOE—type 2 diabetes mellitus	6.21e-05	0.00031	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—LEP—type 2 diabetes mellitus	6.21e-05	0.00031	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—APOA1—type 2 diabetes mellitus	6.14e-05	0.000306	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	6.09e-05	0.000304	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	6.08e-05	0.000304	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—GNB3—type 2 diabetes mellitus	6.03e-05	0.000301	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CCR5—type 2 diabetes mellitus	5.98e-05	0.000299	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—AVP—type 2 diabetes mellitus	5.95e-05	0.000297	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—MMP3—type 2 diabetes mellitus	5.95e-05	0.000297	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—IGF2—type 2 diabetes mellitus	5.92e-05	0.000295	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	5.89e-05	0.000294	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	5.85e-05	0.000292	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—C3—type 2 diabetes mellitus	5.85e-05	0.000292	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	5.83e-05	0.000291	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—APOB—type 2 diabetes mellitus	5.75e-05	0.000287	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	5.72e-05	0.000286	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—EDN1—type 2 diabetes mellitus	5.66e-05	0.000282	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	5.58e-05	0.000278	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—IRS2—type 2 diabetes mellitus	5.56e-05	0.000278	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—AGT—type 2 diabetes mellitus	5.55e-05	0.000277	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—IRS1—type 2 diabetes mellitus	5.54e-05	0.000276	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—LPL—type 2 diabetes mellitus	5.49e-05	0.000274	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CALM1—type 2 diabetes mellitus	5.46e-05	0.000273	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—LEP—type 2 diabetes mellitus	5.44e-05	0.000272	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—APOE—type 2 diabetes mellitus	5.44e-05	0.000272	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—APOA1—type 2 diabetes mellitus	5.38e-05	0.000268	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	5.37e-05	0.000268	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—INS—type 2 diabetes mellitus	5.3e-05	0.000265	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CCL2—type 2 diabetes mellitus	5.22e-05	0.00026	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	5.15e-05	0.000257	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	5.13e-05	0.000256	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—IGF1—type 2 diabetes mellitus	5.13e-05	0.000256	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—AKT2—type 2 diabetes mellitus	5.13e-05	0.000256	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	5.1e-05	0.000255	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CCR5—type 2 diabetes mellitus	5.06e-05	0.000252	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—C3—type 2 diabetes mellitus	4.94e-05	0.000247	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	4.87e-05	0.000243	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—IRS1—type 2 diabetes mellitus	4.86e-05	0.000242	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	4.71e-05	0.000235	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—IRS2—type 2 diabetes mellitus	4.7e-05	0.000235	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—AGT—type 2 diabetes mellitus	4.69e-05	0.000234	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	4.65e-05	0.000232	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—NOS3—type 2 diabetes mellitus	4.65e-05	0.000232	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—INS—type 2 diabetes mellitus	4.65e-05	0.000232	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CALM1—type 2 diabetes mellitus	4.62e-05	0.00023	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—APOE—type 2 diabetes mellitus	4.6e-05	0.00023	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—LEP—type 2 diabetes mellitus	4.6e-05	0.00023	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CCL2—type 2 diabetes mellitus	4.57e-05	0.000228	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—APOA1—type 2 diabetes mellitus	4.55e-05	0.000227	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—IGF1—type 2 diabetes mellitus	4.5e-05	0.000224	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—AKT2—type 2 diabetes mellitus	4.49e-05	0.000224	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	4.47e-05	0.000223	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—RELA—type 2 diabetes mellitus	4.38e-05	0.000218	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	4.34e-05	0.000216	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	4.27e-05	0.000213	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—IRS1—type 2 diabetes mellitus	4.1e-05	0.000205	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	4.08e-05	0.000203	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—NOS3—type 2 diabetes mellitus	4.08e-05	0.000203	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	3.98e-05	0.000199	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.95e-05	0.000197	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—INS—type 2 diabetes mellitus	3.93e-05	0.000196	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—IL6—type 2 diabetes mellitus	3.92e-05	0.000196	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CCL2—type 2 diabetes mellitus	3.87e-05	0.000193	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—RELA—type 2 diabetes mellitus	3.84e-05	0.000192	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—IGF1—type 2 diabetes mellitus	3.8e-05	0.00019	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—AKT2—type 2 diabetes mellitus	3.8e-05	0.00019	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	3.78e-05	0.000189	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.73e-05	0.000186	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.69e-05	0.000184	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	3.62e-05	0.000181	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	3.61e-05	0.00018	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	3.49e-05	0.000174	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.46e-05	0.000173	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—NOS3—type 2 diabetes mellitus	3.45e-05	0.000172	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	3.45e-05	0.000172	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—SRC—type 2 diabetes mellitus	3.44e-05	0.000172	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—IL6—type 2 diabetes mellitus	3.44e-05	0.000172	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.35e-05	0.000167	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.27e-05	0.000163	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—RELA—type 2 diabetes mellitus	3.24e-05	0.000162	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.24e-05	0.000162	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	3.17e-05	0.000158	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.07e-05	0.000153	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—SRC—type 2 diabetes mellitus	3.02e-05	0.00015	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.01e-05	0.00015	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.95e-05	0.000147	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.94e-05	0.000147	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.93e-05	0.000146	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.91e-05	0.000145	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.76e-05	0.000138	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.74e-05	0.000136	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.7e-05	0.000135	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.68e-05	0.000134	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.64e-05	0.000132	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—SRC—type 2 diabetes mellitus	2.55e-05	0.000127	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.48e-05	0.000124	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—IL6—type 2 diabetes mellitus	2.32e-05	0.000116	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.28e-05	0.000114	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.23e-05	0.000111	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.14e-05	0.000107	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—IL6—type 2 diabetes mellitus	2.03e-05	0.000101	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.87e-05	9.35e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—IL6—type 2 diabetes mellitus	1.72e-05	8.57e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.58e-05	7.9e-05	CbGpPWpGaD
